| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | LOXO ONCOLOGY INC COM | 4,028,920 | 129,409,000 | 30.09% | ||
| 2 | ZELTIQ AESTHETICS INCORPORATED | 1,609,727 | 70,056,000 | 16.29% | ||
| 3 | AIMMUNE THERAPEUTICS INC COM | 2,990,000 | 61,146,000 | 14.22% | ||
| 4 | VERSARTIS INC COM | 2,524,465 | 37,615,000 | 8.74% | ||
| 5 | VIEWRAY INC | 7,480,887 | 23,415,000 | 5.44% | ||
| 6 | Esperion Therapeutics Inc | 1,637,125 | 20,497,000 | 4.77% | ||
| 7 | ADMA BIOLOGICS, INC. | 3,608,171 | 18,474,000 | 4.29% | ||
| 8 | T2 BIOSYSTEMS INC | 2,830,992 | 14,891,000 | 3.46% | ||
| 9 | TRANSENTERIX INC | 8,335,819 | 10,837,000 | 2.52% | ||
| 10 | CIDARA THERAPEUTICS INC | 1,021,148 | 10,620,000 | 2.47% | ||
| 11 | Agile Therapeutics, Inc. | 1,804,933 | 10,288,000 | 2.39% | ||
| 12 | PARATEK PHARMACEUTICALS INC | 482,680 | 7,433,000 | 1.73% | ||
| 13 | SYROS PHARMACEUTICALS INC | 508,565 | 6,184,000 | 1.44% | ||
| 14 | CEMPRA INC | 1,193,060 | 3,341,000 | 0.78% | ||
| 15 | Intersect ENT Inc | 225,000 | 2,723,000 | 0.63% | ||
| 16 | CHIMERIX INC | 472,943 | 2,176,000 | 0.51% | ||
| 17 | PERNIX THERAPEUTICS HOLDINGS INC | 2,500,000 | 625,000 | 0.15% | PRN | |
| 18 | PERNIX THERAPEUTICS | 210,000 | 407,000 | 0.09% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950142-17-000304, filed 2017.02.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
